A Therapeutic Target for Microvascular Complications in Diabetes: Endothelium- Derived Hyperpolarizing Factor

Publisher： Bentham Science Publishers

E-ISSN： 1875-6557|2|3|185-191

ISSN： 1573-403X

Source： Current Cardiology Reviews, Vol.2, Iss.3, 2006-08, pp. : 185-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Significance of Endothelium-Derived Hyperpolarizing Factor in the Human Circulation

By  

Current Vascular Pharmacology, Vol. 5, Iss. 1, 2007-01 ,pp. : 85-92

Bentham Science Publishers

Access to resources Recommend Favorite

Adiponectin: An Endothelium-Derived Vasoprotective Factor?

By  

Current Vascular Pharmacology, Vol. 14, Iss. 2, 2016-03 ,pp. : 168-174

Bentham Science Publishers

Access to resources Recommend Favorite

THE ASSOCIATION OF REDUCED ENDOTHELIUM DERIVED RELAXING FACTOR-NO PRODUCTION WITH ENDOTHELIAL DAMAGE AND INCREASED IN VIVO PLATELET ACTIVATION IN PATIENTS WITH DIABETES MELLITUS

By Huszka M.   Kaplar M.   Rejto L.   Tornai I.   Palatka K.   Laszlo P.   Udvardy M.  

Thrombosis Research, Vol. 86, Iss. 2, 1997-04 ,pp. : 173-180

Elsevier

Access to resources Recommend Favorite

Editorial (Thematic Issue: Endothelium: A Target for Therapeutic Intervention)

By  

Current Vascular Pharmacology, Vol. 14, Iss. 2, 2016-03 ,pp. : 126-129

Bentham Science Publishers

Access to resources Recommend Favorite

Plasmatic nitric oxide, but not von Willebrand Factor, is an early marker of endothelial damage, in type 1 diabetes mellitus patients without microvascular complications

By Correa R.C.   Alfieri A.B.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 5, 2003-09 ,pp. : 264-268

Elsevier

Access to resources Recommend Favorite